Today, we would like to share with you a biotech company from Georgia – CryoLife , which is doing interesting work in the area of Cardiovascular Medical Devices and Tissues.
CryoLife Inc. (NYSE:CRY) is engaged in medical device manufacturing and distribution, and in the processing and distribution of implantable human tissues for cardiac and vascular surgeries. The Company operates in two segments: Medical Devices and Preservation Services.
- The Medical Devices segment sells BioGlue, BioFoam, PerClot, CardioGenesis cardiac laser therapy, Hemodialysis Reliable Outflow (HeRO) Graft, and ProCol Vascular Bioprosthesis (ProCol).
- The Preservation Services segment preserves cardiac and vascular tissues. The Company’s surgical sealants and hemostats include BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam), and PerClot, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (SMI). Its CardioGenesis cardiac laser therapy product line includes a laser console system and single-use, fiber-optic handpieces.
Officers and Directors
James Patrick Mackin – Chairman of the Board, President, CEO
D. Ashley Lee CPA – CFO, COO, Executive VP
James M McDermid – Chief Human Resource Officer
John Davis Senior VP – Global Sales and Marketing
William Matthews Senior VP – Operations, Quality, and Regulatory
Amy D. Horton CPA – Chief Accounting Officer
Jean F. Holloway – Compliance, VP, General Counsel, Secretary
Scott B. Capps – VP Clinical Research
David C. Gale Ph.D. – VP Research & Development
James W. Bullock – Director
1655 Roberts Blvd NW
KENNESAW, GA 30144